Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants

Cochrane Database of Systematic Reviews

Volumn 2020, Issue 2, 2020, Pages

  Ohlsson, Arne ^a   Walia, Rajneesh ^b   Shah, Sachin S ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c Surya Hospital for Women and Children   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOOXYGENASE 2 INHIBITOR; IBUPROFEN; INDOMETACIN; PLACEBO; ENZYME INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR;

CONTINUOUS INFUSION; CREATININE BLOOD LEVEL; DATA ANALYSIS; DRUG CHOICE; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG MEGADOSE; DRUG SAFETY; EARLY INTERVENTION; ECHOCARDIOGRAPHY; HUMAN; INFORMATION PROCESSING; KIDNEY FAILURE; LOW BIRTH WEIGHT; NECROTIZING ENTEROCOLITIS; OLIGURIA; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WATCHFUL WAITING; META ANALYSIS; NEWBORN;

CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS, PATENT; ENZYME INHIBITORS; HUMANS; IBUPROFEN; INDOMETHACIN; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85079310138     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD003481.pub8     Document Type: Review

References (127)

1. Adamska E, Helwich E, Rutkowska M, Zacharska E, Piotrowska A. Comparison of the efficacy of ibuprofen and indomethacin in the treatment of patent ductus arteriosus in prematurely born infants [Porownanie ibuprofenu i indometacyny w leczeniu przetrwalego przewodu tetniczego u noworodkow urodzonych przedwczesnie]. Medycyna Wieku Rozwojowego 2005;9(3 Pt 1):335-54. [PUBMED: 16547381]x-wiley/crsRef/2880832
2. Akar M, Yildirim TG, Sandal G, Bozdag S, Erdeve O, Altug N, et al. Does ibuprofen treatment in patent ductus arteriosus alter oxygen free radicals in premature infants?. Cardiology in the Young 2017;27(3):507–11. [PUBMED: 27319277]x-wiley/crsRef/9247259
3. Akisu M, Ozyurek AR, Dorak C, Parlar A, Kultursay N. Enteral ibuprofen versus indomethacin in the treatment of patent ductus arteriosus in preterm newborn infants [Premature bebeklerde patent duktus arteriozusun tedavisinde enteral ibuprofen ve indometazinin etkinligi ve guvenilirligi]. Cocuk Sagligi ve Hastaliklari Dergisi 2001;44(1):56-60. x-wiley/crsRef/2880834
4. Aly H, Lotfy W, Badrawi N, Ghawas M, Abdel-Meguid IE, Hammad TA. Oral ibuprofen and ductus arteriosus in premature infants: a randomized pilot study. American Journal of Perinatology 2007;24(5):267-70. [PUBMED: 17484080]x-wiley/crsRef/2880836
5. Lotfy W, Badrawi N, Ghawas M, Ehsan E, Aly H. Oral ibuprofen solution (O) is efficacious for the treatment of patent ductus arteriosus (PDA) in premature infants: a randomized controlled trial. Pediatric Academic Societies Annual Meeting; 2005 May 14-17; Washington DC, United States. 2005. [PAS2005:1410]x-wiley/crsRef/2880837
6. Aranda JV. Multicentre randomized double-blind placebo controlled trial of ibuprofen L-Lysine intravenous solution (IV Ibuprofen) in premature infants for the early treatment of patent ductus arteriosus (PDA). Pediatric Academic Societies Annual Meeting; 2005 May 14-17; Washington DC, United States. 2005. x-wiley/crsRef/9247262
7. Aranda JV, Clyman R, Cox B, Van Overmeire B, Wozniak P, Sosenko I, et al. A randomized, double-blind, placebo-controlled trial of intravenous ibuprofen L-lysine for the early closure of non-symptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants. American Journal of Perinatology 2009;26(3):235-45. [DOI: 10.1055/s-0028-1103515; PUBMED: 19067286]x-wiley/crsRef/9247261
8. Bagnoli F, Rossetti A, Messina G, Mori A, Casucci M, Tomasini B. Treatment of patent ductus arteriosus (PDA) using ibuprofen: renal side-effects in VLBW and ELBW newborns. Journal of Maternal-Fetal & Neonatal Medicine 2013;26(4):423-9. [DOI: 10.3109/14767058.2012.733775; PUBMED: 23057804]x-wiley/crsRef/2880842
9. Bravo MC, Cabaňas F, Riera J, Pérez-Fernández E, Quero J, Pérez-Rodriguez J, et al. Randomized controlled clinical trial of standard versus echocardiographically guided ibuprofen treatment for patent ductus arteriosus in preterm infants: a pilot study. Journal of Maternal-Fetal & Neonatal Medicine 2014;27(9):904-9. [DOI: 10.3109/14767058.2013.846312; PUBMED: 24047189]x-wiley/crsRef/2880844
10. Cherif A, Khrouf N, Jabnoun S, Mokrani C, Amara MB, Guellouze N, et al. Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus. Pediatrics 2008;122(6):e1256-61. [PUBMED: 19047225]x-wiley/crsRef/2880846
11. Chotigeat U, Jirapapa K, Layangkool T. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. Chotmaihet Thangphaet [Journal of the Medical Association of Thailand] 2003;86(Suppl 3):S563-9. [PUBMED: 14700149]x-wiley/crsRef/2880848
12. Dani C, Vangi V, Bertini G, Pratesi S, Lori I, Favelli F, et al. High-dose ibuprofen for patent ductus arteriosus in extremely preterm infants: a randomized controlled study. Clinical Pharmacology and Therapeutics 2012;91(4):590-6. [PUBMED: 22089267]x-wiley/crsRef/2880850
13. Demir N, Peker E, Ece I, Balahoroglu R, Tuncer O. Efficacy and safety of rectal ibuprofen for ductus arteriosus closure in very low birth weight infants. European Journal of Pediatrics 2016;175(11):1705-6. x-wiley/crsRef/9247264
14. Demir N, Peker E, Ece I, Balahoroglu R, Tuncer O. Efficacy and safety of rectal ibuprofen for patent ductus arteriosus closure in very low birth weight preterm infants. Journal of Maternal-Fetal & Neonatal Medicine 2017;30(17):2119–25. [DOI: 10.1080/14767058.2016.1238897; PUBMED: 28052714]x-wiley/crsRef/9247265
15. Peker E, Demir N, Ece I, Balahorotlu R, Tuncer O. Efficacy and safety of rectal ibuprofen for ductus arteriosus closure in very low birth weight infants. Journal of Maternal-Fetal & Neonatal Medicine 2016;29(Suppl 1):114. x-wiley/crsRef/9247266
16. Ding YJ, Han B, Yang B, Zhu M. NT-proBNP plays an important role in the effect of ibuprofen on preterm infants with patent ductus arteriosus. European Review for Medical and Pharmacological Sciences 2014;18(18):2596-8. [PUBMED: 25317790]x-wiley/crsRef/2880918
17. El-Mashad AE, El-Mahdy H, El Amrousy DE, Elgendy M. Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates. European Journal of Pediatrics 2017;176(2):233-40. [DOI: 10.1007/s00431-016-2830-7; PUBMED: 28004188]x-wiley/crsRef/9247268
18. Erdeve O, Yurttutan S, Altug N, Ozdemir R, Gokmen T, Dilmen U, et al. Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants. Archives of Disease in Childhood. Fetal and Neonatal Edition 2012;97(4):F279-83. [DOI: 10.1136/archdischild-2011-300532; PUBMED: 22147286]x-wiley/crsRef/2880852
19. Fakhraee SH, Badiee Z, Mojtahedzadeh S, Kazemian M, Kelishadi R. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Zhongguo Dang Dai Er Ke za Zhi [Chinese Journal of Contemporary Pediatrics] 2007;9(5):399-403. [PUBMED: 17937843]x-wiley/crsRef/2880854
20. Fesharaki HJ, Nayeri FS, Asbaq PA, Amini E, Sedagat M. Different doses of ibuprofen in the treatment of patent ductus arteriosus: a randomized controlled trial. Tehran University Medical Journal 2012;70(8):488-93. x-wiley/crsRef/2880856
21. Gimeno Navarro A, Cano Sanchez A, Fernandez Gilino C, Carrasco Moreno JI, Izquierdo Macian I, Gutierrez Laso A, et al. Ibuprofen versus indomethacin in the treatment of patent ductus arteriosus in preterm infants [Ibuprofeno frente a indometacina en el tratamiento del conducto arterioso persistente del prematuro]. Anales de Pediatria 2005;63(3):212-8. [PUBMED: 16219273]x-wiley/crsRef/2880858
22. Eras Z, Gokmen T, Erdeve O, Ozyurt BM, Saridas B, Dilmen U. Impact of oral versus intravenous ibuprofen on neurodevelopmental outcome: a randomized controlled parallel study. American Journal of Perinatology 2013;30(10):857-62. [DOI: 10.1055/s-0033-1333667; PUBMED: 23359230]x-wiley/crsRef/2880860
23. Gokmen T, Erdeve O, Altug N, Oguz SS, Uras N, Dilmen U. Efficacy and safety of oral verus intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus. Journal of Pediatrics 2011;158(4):549-54; Erratum in: Journal of Pediatrics; 2012;160(1):181. [10.1016/j.jpeds.2010.10.008; PUBMED: 21094951]x-wiley/crsRef/2880861
24. Hammerman C, Shchors I, Jacobson S, Schimmel MS, Bromiker R, Kaplan M, et al. Ibuprofen versus continuous indomethacin in premature neonates with patent ductus arteriosus: is the difference in the mode of administration?. Pediatric Research 2008;64(3):291-7. [DOI: 10.1203/PDR.0b013e31817d9bb0; PUBMED: 18458658]x-wiley/crsRef/2880863
25. Lago P, Bettiol T, Salvadori S, Pitassi I, Vianello A, Chiandetti L, et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. European Journal of Pediatrics 2002;161(4):202-7. [PUBMED: 12014386]x-wiley/crsRef/2880865
26. Lago P, Salvadori S, Bettiol T, Pitassi I, Chiandetti L, Saia OS. Effects of indomethacin and ibuprofen on renal function in preterm infants treated for patent ductus arteriosus: a randomized controlled trial. Pediatric Research 2001;49:375A. x-wiley/crsRef/2880866
27. Zanardo V, Vedovato S, Lago P, Piva D, Faggian D, Chiozza L. Effects of ibuprofen and indomethacin on urinary antidiuretic hormone excretion in preterm infants treated for patent ductus arteriosus. Fetal Diagnosis and Therapy 2005;20(6):534-9. [DOI: 10.1159/000088046; PUBMED: 16260891]x-wiley/crsRef/2880867
28. Lago P, Salvadori S, Opocher F, Ricato S, Chiandetti L, Frigo AC. Continuous infusion of ibuprofen for treatment of patent ductus arteriosus in very low birth weight infants. Neonatology 2014;105(1):46-54. [DOI: 10.1159/000355679; PUBMED: 24281435]x-wiley/crsRef/2880869
29. Lin XZ, Chen HQ, Zheng Z, Li YD, Lai JD, Huang LH. Therapeutic effect of early administration of oral ibuprofen in very low birth weight infants with patent ductus arteriosus. Zhongguo Dang Dai Er Ke za Zhi [Chinese Journal of Contemporary Pediatrics] 2012;14(7):502-5. [PUBMED: 22809601]x-wiley/crsRef/2880871
30. Lin YJ, Chen CM, Rehan VK, Florens A, Wu SY, Tsai ML, et al. Randomized trial to compare renal function and ductal response between Indomethacin and ibuprofen treatment in extremely low birth weight infants. Neonatology 2017;111(3):195–202. [DOI: 10.1159/000450822; PUBMED: 27842315]x-wiley/crsRef/9247270
31. Mosca F, Bray M, Lattanzio M, Fumagalli M, Colnaghi M, Castoldi F, et al. Comparison of the effects of ibuprofen and indomethacin on PDA closure and cerebral perfusion and oxygenation. Pediatric Research 1997;41:165A. x-wiley/crsRef/2880873
32. Mosca F, Bray M, Lattanzio M, Fumagalli M, Colnaghi MR, Compagnoni G. Comparison of the effects of indomethacin (INDO) and ibuprofen (IBU) on cerebral perfusion and oxygenation in preterm infants. Pediatric Research 1996;39:231A. x-wiley/crsRef/2880874
33. Mosca F, Bray M, Lattanzio M, Fumagalli M, Tosetto C. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. Journal of Pediatrics 1997;131(4):549-54. [PUBMED: 9386657]x-wiley/crsRef/2880875
34. Patel J, Marks KA, Roberts I, Azzopardi D, Edwards AD. Ibuprofen treatment of patent ductus arteriosus. Lancet 1995;346(8969):255. [PUBMED: 7616831]x-wiley/crsRef/2880877
35. Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards AD. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatric Research 2000;47(1):36-42. [PUBMED: 10625080]x-wiley/crsRef/2880879
36. Pezzati M, Bertini G, Vangi V, Biagiotti R, Cianciulli D, Rubaltelli FF. Mesenteric and renal perfusion in preterm infants with PDA: indomethacin vs ibuprofen. Pediatric Research 1999;45:218A. x-wiley/crsRef/2880881
37. Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubatelli FF. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. Journal of Pediatrics 1999;135(6):733-8. [PUBMED: 10586177]x-wiley/crsRef/2880882
38. Hoxha A, Gjyzari A, Tushe E. Renal effects of ibuprofen during the treatment of patent ductus arteriosus in low birth weight premature infants. Nephrology Dialysis Transplantation Conference. 50th ERA-EDTA Congress; 2013 May 18-21; Istanbul, Turkey. 2013. x-wiley/crsRef/2880884
39. Pistulli E, Hamiti A, Buba S, Hoxha A, Kelmendi N, Vyshka G. The association between patent ductus arteriosus and perinatal infection in a group of low birth weight preterm infants. Iranian Journal of Pediatrics 2014;24(1):42-8. [PUBMED: 25793044]x-wiley/crsRef/2880885
40. Prifti E, Enkeleda P, Rubena M, Alketa H. The impact of antenatal corticosteroids on PDA in low birth weight infants. Journal of Perinatal Medicine 2013;41:s1. x-wiley/crsRef/2880886
41. Qosja A, Kuneshka N, Tushe E, Teneqexhi L. Oral versus intravenous ibuprofen for patent ductus arteriosus closure. Giornale Italiano di Cardiologia 2012;13(Suppl 1):15S-6S. x-wiley/crsRef/2880887
42. Plavka R, Svihovec P, Borek I, Biolek J, Kostirova M, Liska K, et al. Ibuprofen vs. indomethacin in the treatment of patent ductus arteriosus (PDA) in very premature neonates. Pediatric Research 2001;49:375A. x-wiley/crsRef/2880889
43. Pourarian SH, Pishva N, Madani A, Rastegari M. Comparison of oral ibuprofen and indomethacin on closure of patent ductus arteriosus in preterm infants. Eastern Mediterranean Health Journal 2008;14(2):360-5. [PUBMED: 18561728]x-wiley/crsRef/2880891
44. Pourarian S, Takmil F, Cheriki S, Amoozgar H. The effect of oral high-dose ibuprofen on patent ductus arteriosus closure in preterm infants. American Journal of Perinatology 2015;32(12):1158-63. [DOI: 10.1055/s-0035-1551671; PUBMED: 26007314]x-wiley/crsRef/9247272
45. Salama H, Alsisi A, Al-Rifai H, Shaddad A, Samawal L, Habboub L, et al. A randomized controlled trial on the use of oral ibuprofen to close patent ductus arteriosus in premature infants. Journal of Neonatal-Perinatal Medicine 2008;1(3):153-8. x-wiley/crsRef/2880893
46. Sosenko IR, Fajardo MF, Claure N, Bancalari E. Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial. Journal of Pediatrics 2012;160(6):929-35. [PUBMED: 22284563]x-wiley/crsRef/2880895
47. Su PH, Chen JY, Su CM, Huang TC, Lee HS. Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Pediatrics International 2003;45(6):665-70. [PUBMED: 14651538]x-wiley/crsRef/2880897
48. Su BH, Lin HC, Chiu HY, Hsieh HY, Chen HH, Tsai YC. Comparison of ibuprofen and indomethacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomised controlled trial. Archives of Disease in Childhood. Fetal and Neonatal Edition 2008;93(2):F94-9. [DOI: 10.1136/adc.2007.120584; PUBMED: 17768157]x-wiley/crsRef/2880899
49. Supapannachart S, Limrungsikul A, Khowsathit P. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. Chotmaihet Thangphaet [Journal of the Medical Association of Thailand] 2002;85(Suppl 4):S1252-8. [PUBMED: 12549803]x-wiley/crsRef/2880901
50. Van Overmeire B, Follens I, Hartmann S, Creten WL, Van Acker KJ. Treatment of patent ductus arteriosus with ibuprofen. Archives of Disease in Childhood. Fetal and Neonatal Edition 1997;76(3):F179-84. [PUBMED: 9175948]x-wiley/crsRef/2880903
51. Van Overmeire B, Follens I, Hartmann S, Mahieu L, Van Reempts PJ. Intravenous ibuprofen (IBU) for the treatment of patent ductus arteriosus (PDA) in preterm infants with respiratory distress syndrome (RDS). Pediatric Research 1996;39:250A. x-wiley/crsRef/2880904
52. Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli FF. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. Journal of Pediatrics 1999;135(6):733-8. [PUBMED: 10586177]x-wiley/crsRef/2880906
53. Van Overmeire B, Langhendries JP, Vanhaesebrouck P, Lecoutere D, Van de Broek H. Ibuprofen for early treatment of patent ductus arteriosus, a randomized multicentre trial. Pediatric Research 1998;43:200A. x-wiley/crsRef/2880907
54. Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, De Groote K, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. New England Journal of Medicine 2000;343(10):674-81. [DOI: 10.1056/NEJM200009073431001; PUBMED: 10974130]x-wiley/crsRef/2880908
55. Yadav S, Agarwal S, Maria A, Dudeja A, Dubey NK, Anand P, et al. Comparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: a randomized controlled trial. Pediatric Cardiology 2014;35(5):824-30. [DOI: 10.1007/s00246-014-0861-2; PUBMED: 24435507]x-wiley/crsRef/2880910
56. Alipour MR, Shamsi MM, Namayandeh SM, Pezeshkpour Z, Rezaeipour F, Sarebanhassanabadi M. The effects of oral ibuprofen on medicinal closure of patent ductus arteriosus in full-term neonates in the second postnatal week. Iranian Journal of Pediatrics 2016;26(4):e5807. [DOI: 10.5812/ijp.5807; PUBMED: 27729962]x-wiley/crsRef/9247274
57. Amoozgar H, Ghodstehrani M, Pishva N. Oral ibuprofen and ductus arteriosus closure in full-term neonates: a prospective case-control study. Pediatric Cardiology 2010;31(1):40-3. [DOI: 10.1007/s00246-009-9542-y; PUBMED: 19841966]x-wiley/crsRef/2880912
58. Cherif A, Jabnoun S, Khrouf N. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants. American Journal of Perinatology 2007;24(6):339-45. [DOI: 10.1055/s-2007-981853; PUBMED: 17564958]x-wiley/crsRef/2880914
59. Desfrere L, Zohar S, Morville P, Brunhes A, Chevret S, Pons G, et al. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method. Journal of Clinical Pharmacy and Therapeutics 2005;30(2):121-32. [DOI: 10.1111/j.1365-2710.2005.00630.x; PUBMED: 15811164]x-wiley/crsRef/2880916
60. Kalani M, Shariat M, Khalesi N, Farahani Z, Ahmadi S. A comparison of early ibuprofen and indomethacin administration to prevent intraventricular hemorrhage among preterm infants. Acta Medica Iranica 2016;54(12):788-92. [PUBMED: 28120591]x-wiley/crsRef/9247276
61. ACTRN12616000195459. Early pharmacological treatment with supportive care versus supportive care alone in preterm infants with a patent ductus arteriosus. anzctr.org.au/ACTRN12616000195459.aspx (first received 08 February 2016). x-wiley/crsRef/9247278
62. ChiCTR-TRC-14004559. Comparison of the dose effect of oral ibuprofen suspension for PDA treatment in premature infants [Developmental pharmacokinetics and pharmacodynamics of chiral ibuprofen associated with the CYP2C8/9 gene polymorphism]. chictr.org.cn/showproj.aspx?proj=5014 (first received 15 April 2014). x-wiley/crsRef/9247280
63. EUCTR2016-002974-11-ES. Clinical trial to evaluate the impact on the intestinal prognosis of 2 ibuprofen administration regimens for the treatment of patent ductus arteriosus, guided by echocardiography [Phase III, randomized, multicenter, double-blind clinical trial to evaluate two echo-guided administration regimens of ibuprofen in the treatment of patent ductus arteriosus: impact on intestinal prognosis]. clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002974-11 (first received 26 September 2016). x-wiley/crsRef/9247282
64. IRCT201205029611N1. High dose oral ibuprofen in PDA closure in premature infants. en.irct.ir/trial/10178 (first received 25 August 2014). x-wiley/crsRef/9247284
65. IRCT2015111024977N1. Comparison of oral Ibuprofen and intravenous indomethacin for the treatment of patent ductus arteriosus [Comparison of oral Ibuprofen and intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants]. en.irct.ir/trial/20973 (first received 16 December 2015). x-wiley/crsRef/9247286
66. ISRCTN13281214. Closing patent ductus arteriosus in preterm babies by using a risk-based score. isrctn.com/ISRCTN13281214?q=ISRCTN13281214&filters=&sort=&offset=1&totalResults=1&page=1&pageSize=10&searchType=basic-search (first received 1 July 2016). x-wiley/crsRef/9247288
67. NCT01149564. Comparison of oral and intravenous ibuprofen for PDA treatment in premature infants. clinicaltrials.gov/show/NCT01149564 (first received 23 June 2010). x-wiley/crsRef/2880920
68. NCT01630278. Early ibuprofen treatment of patent ductus arteriosus (PDA) in premature infants (TRIOCAPI) [Impact of early targeted ibuprofene treatment of patent ductus arteriosus (PDA) on long term neurodevelopmental outcome in very premature infants (TRIOCAPI)]. clinicaltrials.gov/show/NCT01630278 (first received 28 June 2012). x-wiley/crsRef/2880922
69. NCT01758913. Closure of patent ductus arteriosus with indomethacin or ibuprofen in extreme low birth weight infants [Pharmacological closure of patent ductus arteriosus in extreme low birth weight infants. A comparison of efficacy, side effects and outcomes between indomethacin and ibuprofen]. clinicaltrials.gov/show/NCT01758913 (first received 1 January 2013). x-wiley/crsRef/2880924
70. NCT02128191. No treatment versus ibuprofen treatment for patent ductus arteriosus in preterm infants [Efficacy and safety of no treatment compared with oral ibuprofen treatment for patent ductus arteriosus in preterm infants: a randomized, double-blind, placebo-controlled, non-inferiority clinical trial]. clinicaltrials.gov/show/NCT02128191 (first received 1 May 2014). x-wiley/crsRef/2880926
71. NCT02884219. Early treatment versus expectative management of PDA in preterm infants [Multi-center, randomized non-inferiority trial of early treatment versus expectative management of patent ductus arteriosus in preterm infants (BeNeDuctus Trial - Belgium Netherlands Ductus Trial)]. clinicaltrials.gov/ct2/show/record/NCT02884219 (first received 30 August 2016). x-wiley/crsRef/9247290
72. Amendolia B, Lynn M, Bhat V, Ritz SB, Aghai ZH. Severe pulmonary hypertension with therapeutic L-lysine ibuprofen in 2 preterm infants. Pediatrics 2012;129(5):e1360-3. [DOI: 10.1542/peds.2011-0117; PUBMED: 22492771]
73. Bellini C, Campone F, Serra G. Pulmonary hypertension following L-lysine ibuprofen therapy in a preterm infant with patent ductus arteriosus. Canadian Medical Association Journal 2006;174(13):1843-4. [DOI: 10.1503/cmaj.051446; PUBMED: 16785458]
74. Bravo MC, Cordeiro M, Deiros L, Pérez-Rodríguez J. Lethal pulmonary hypertension associated with ibuprofen treatment in a very low birth weight infant. Journal of Paediatrics and Child Health 2014;50(1):85-6. [DOI: 10.1111/jpc.12445; PUBMED: 24397458]
75. Chemtob S, Behary K, Rex J, Varma DR, Aranda JV. Prostanoids determine the range of cerebral blood flow autoregulation of newborn piglets. Stroke 1990;21(5):777-84. [PUBMED: 2339458]
76. Chemtob S, Beharry K, Barna T, Varma DR, Aranda JV. Differences in the effects in the newborn piglet of various nonsteroidal antiinflammatory drugs on cerebral blood flow but not on cerebrovascular prostaglandins. Pediatric Research 1991;30(1):106-11. [DOI: 10.1203/00006450-199107000-00021; PUBMED: 1891274]
77. Coceani F, White E, Bodach E, Olley PM. Age-dependent changes in the responses of the lamb ductus arteriosus to oxygen and ibuprofen. Canadian Journal of Physiology and Pharmacology 1979;57(8):825-31. [PUBMED: 497895]
78. Coceani F, Barogi S, Brizza F, Ackerley C, Seidlitz E, Kelsey L, et al. Cyclooxygenase isoenzymes and patency of ductus arteriosus. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2005;72(2):71-7. [DOI: 10.1016/j.plefa.2004.10.004; PUBMED: 15626588]
79. Cotton RB, Stahlman MT, Kovar I, Catterton WZ. Medical management of small preterm infants with symptomatic patent ductus arteriosus. Journal of Pediatrics 1978;92(3):467-73. [PUBMED: 632994]
80. Cotton RB, Stahlman MT, Bender HW, Graham TP, Catterton WZ, Kovar I. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. Journal of Pediatrics 1978;93(4):647-51. [PUBMED: 702245]
81. Edwards AD, Wyatt JS, Richardson C, Potter A, Cope M, Delpy DT, et al. Effects of indomethacin on cerebral haemodynamics in very preterm infants. Lancet 1990;335(8704):1491-5. [PUBMED: 1972434]
82. ElHassan NO, Bird TM, King AJ, Ambadwar PB, Jaquiss RD, Kaiser JR, et al. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants. Journal of Neonatal-Perinatal Medicine 2014;7(3):229-35. [DOI: 10.3233/NPM-14814015; PUBMED: 25322995]
83. Ellison RC, Pecham GJ, Lang P, Talner NS, Lerer TJ, Lin L, et al. Evaluation of the preterm infant for patent ductus arteriosus. Pediatrics 1983;71(3):364-72. [PUBMED: 6338474]
84. Fowlie PW, Davis PG, McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database of Systematic Reviews 2010, Issue 7. [DOI: 10.1002/14651858.CD000174.pub2]
85. Gournay V, Savagner C, Thirez G, Kuster A, Roze JC. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet 2002;359(9316):1486-8. [PUBMED: 11988250]
86. McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 30 November 2017. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.
87. Grosfeld JL, Kamman K, Gross K, Cikrit D, Ross D, Wolfe M, et al. Comparative effects of indomethacin, prostaglandin E1, and ibuprofen on bowel ischaemia. Journal of Pediatric Surgery 1983;18(6):738-42. [PUBMED: 6686609]
88. Hardy P, Peri KG, Lahaie I, Varma DR, Chemtob S. Increased nitric oxide synthesis and action preclude choroidal vasoconstriction to hyperoxia in newborn pigs. Circulation Research 1996;79(3):504-11. [PUBMED: 8781483]
89. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60. [DOI: 10.1136/bmj.327.7414.557; PUBMED: 12958120]
90. Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017. Available from training.cochrane.org/handbook.
91. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology 2005;5:13. [DOI: 10.1186/1471-2288-5-13; PUBMED: 15840177]
92. Ito K, Niida Y, Sato J, Owada E, Ito K, Umetsu M. Pharmacokinetics of mefenamic acid in preterm infants with patent ductus arteriosus. Acta Paediatrica Japonica; Overseas Edition 1994;36(4):387-91. [PUBMED: 7942001]
93. Kaplan BS, Restaino I, Raval DS, Gottlieb RP, Bernstein J. Renal failure in the neonate associated with in utero exposure to non-steroidal anti-inflammatory agents. Pediatric Nephrology (Berlin, Germany) 1994;8(6):700-4. [PUBMED: 7696108]
94. Kim SY, Shin SH, Kim HS, Jung YH, Kim EK, Choi JH. Pulmonary arterial hypertension after ibuprofen treatment for patent ductus arteriosus in very low birth weight infants. Journal of Pediatrics 2016;179:49-53.e1. [DOI: 10.1016/j.jpeds.2016.08.103; PUBMED: 27692860]
95. Lee SK, McMillan DD, Ohlsson A, Pendray M, Synnes A, Whyte R, et al. Variations in practice and outcomes in the Canadian NICU Network: 1996-1997. Pediatrics 2000;106(5):1070-9. [PUBMED: 11061777]
96. Mahony L, Carnero V, Brett C, Heymann MA, Clyman RI. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants. New England Journal of Medicine 1982;306(9):506-10. [DOI: 10.1056/NEJM198203043060903; PUBMED: 7035955]
97. Malikiwi A, Roufaeil C, Tan K, Sehgal A. Indomethacin vs ibuprofen: comparison of efficacy in the setting of conservative therapeutic approach. European Journal of Pediatrics 2015;174(5):615-20. [DOI: 10.1007/s00431-014-2441-0; PUBMED: 25344763]
98. Mathew R. Development of the pulmonary circulation: metabolic aspects. In: Polin RA, Fox WW editor(s). Fetal and Neonatal Physiology. Vol. 1, Philadelphia: W.B. Saunders Company, 1998:924-9.
99. Mitra S, Florez ID, Tamayo ME, Aune D, Mbuagbaw L, Veroniki AA, et al. Effectiveness and safety of treatments used for the management of patent ductus arteriosus (PDA) in preterm infants: a protocol for a systematic review and network meta-analysis. BMJ Open 2016;6(7):e011271. [DOI: 10.1136/bmjopen-2016-011271; PUBMED: 27456327]
100. Naulty CM, Horn S, Conry J, Avery GB. Improved lung compliance after ligation of patent ductus arteriosus in hyaline membrane disease. Journal of Pediatrics 1978;93(4):682-4. [PUBMED: 702251]
101. Neumann R, Schulzke SM, Bührer C. Oral ibuprofen versus intravenous ibuprofen or intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Neonatology 2012;102(1):9-15. [DOI: 10.1159/000335332; PUBMED: 22414850]
102. Niopas I, Mamzoridi K. Determination of indomethacin and mefenamic acid in plasma performance liquid chromatography. Journal of Chromatography. B, Biomedical Applications 1994;656(2):447-50. [PUBMED: 7987501]
103. Ohlsson A, Bottu J, Govan J, Ryan ML, Fong K, Myhr T. The effect of indomethacin on cerebral blood flow velocities in very low birth weight neonates with patent ductus arteriosus. Developmental Pharmacology and Therapeutics 1993;20(1-2):100-6. [PUBMED: 7924757]
104. Ohlsson A. Back to the drawing board. Pediatric Research 2000;47(1):4-5. [PUBMED: 10625075]
105. Ohlsson A, Shah SS. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2011, Issue 7. [DOI: 10.1002/14651858.CD004213.pub3]
106. Ohlsson A, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Systematic Reviews 2018, (4).
107. Oncel MY, Erdeve O. Oral medications regarding their safety and efficacy in the management of patent ductus arteriosus. World Journal of Clinical Pediatrics 2016;5(1):75-81. [DOI: 10.5409/wjcp.v5.i1.75; PUBMED: 26862505]
108. Pellicer A, Aparicio M, Cabanas F, Valverde E, Quero J, Stiris TA. Effect of the cyclo-oxygenase blocker ibuprofen on cerebral blood volume and cerebral blood flow during normocarbia and hypercarbia in newborn piglets. Acta Pediatrica 1999;88(1):82-8. [PUBMED: 10090554]
109. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
110. Rodriguez-Castano MJ, Aleo E, Arruza L. Oral sildenafil for severe pulmonary hypertension developing after ibuprofen use in a neonate. Indian Pediatrics 2016;53(4):349-50. [PUBMED: 27156554]
111. Sakhalkar VS, Merchant RH. Therapy of symptomatic patent ductus arteriosus in preterms with mefenemic acid and indomethacin. Indian Pediatrics 1992;29(3):313-8. [PUBMED: 1612672]
112. Schmidt B, Davis P, Moddeman D, Ohlsson A, Roberts RS, Saigal S, et al. Trial of Indomethacin Prophylaxis in Preterms Investigators. Long-term effect of indomethacin prophylaxis in extremely-low-birth-weight infants. New England Journal of Medicine 2001;344(26):1966-72. [DOI: 10.1056/NEJM200106283442602; PUBMED: 11430325]
113. Schünemann H, Brożek J, Guyatt G, Oxman A, editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. gdt.guidelinedevelopment.org/app/handbook/handbook.html (accessed prior to 31 August 2018).
114. Sehgal A, Kumarshingri PS. Pulmonary hypertension in an infant treated with ibuprofen. Indian Journal of Pediatrics 2013;80(8):697-9 (Epub 2012 Jul 29). [DOI: 10.1007/s12098-012-0829-2; PUBMED: 22843343]
115. Seyberth HW, Rascher W, Hackenthal R, Wille L. Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very low birth weight infants with symptomatic ductus arteriosus. Journal of Pediatrics 1983;103(6):979-84. [PUBMED: 6358443]
116. Stefano JL, Abbasi S, Pearlman SA, Spear ML, Esterly KL, Bhutani VK. Closure of the ductus arteriosus with indomethacin in ventilated neonates with respiratory distress syndrome: effects on pulmonary compliance and ventilation. American Review of Respiratory Disease 1991;143(2):236-9. [DOI: 10.1164/ajrccm/143.2.236; PUBMED: 1990934]
117. Uchiyama A, Nagasawa H, Yamamoto Y, Tatebayashi K, Suzuki H, Yamada K, et al. Clinical aspects of very-low-birthweight infants showing reopening of ductus arteriosus. Pediatrics International 2011;53(3):322-7. [DOI: 10.1111/j.1442-200X.2010.03251.x; PUBMED: 20854286]
118. Van Overmeire B, Langhendries JP, Vanhasebrouck P, Lecoutere D, Van de Broek H. Ibuprofen for early treatment of patent ductus arteriosus, a randomized multicentre trial. Pediatric Research 1998;43:200A.
119. Varvarigou A, Bardin CL, Beharry K, Chemtob S, Papageorgiou A, Aranda JV. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 1996;275(7):539-44. [PUBMED: 8606475]
120. Weir FJ, Ohlsson A, Myhr TL, Fong K, Ryan ML. A patent ductus arteriosus is associated with reduced middle cerebral artery blood flow velocity. European Journal of Pediatrics 1999;158(6):484-7. [PUBMED: 10378397]
121. Wolf WM, Snover DC, Leonard AS. Localized intestinal perforation following intravenous indomethacin in premature infants. Journal of Pediatric Surgery 1989;24(4):409-10. [PUBMED: 2732888]
122. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2003, Issue 2. [DOI: 10.1002/14651858.CD003481]
123. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD003481.pub2]
124. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD003481.pub3]
125. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2010, Issue 4. [DOI: 10.1002/14651858.CD003481.pub4]
126. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2013, Issue 4. [DOI: 10.1002/14651858.CD003481.pub5]
127. Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database of Systematic Reviews 2015, Issue 2. [DOI: 10.1002/14651858.CD003481.pub6]